| Primary |
| Hypertension |
44.1% |
| Drug Use For Unknown Indication |
35.4% |
| Product Used For Unknown Indication |
5.7% |
| Left Ventricular Dysfunction |
2.5% |
| Cardiac Failure Congestive |
2.0% |
| Atrial Fibrillation |
1.3% |
| Arrhythmia |
1.3% |
| Blood Pressure |
1.3% |
| Cardiac Failure |
1.1% |
| Cardiomyopathy |
1.1% |
| Cardiac Disorder |
0.9% |
| Blood Cholesterol Increased |
0.5% |
| Ejection Fraction Decreased |
0.5% |
| Heart Rate Increased |
0.5% |
| Pain |
0.4% |
| Cardiopulmonary Failure |
0.3% |
| Coronary Artery Disease |
0.3% |
| Prophylaxis |
0.3% |
| Cardiac Failure Chronic |
0.2% |
| Myocardial Infarction |
0.2% |
|
| Fatigue |
10.4% |
| Drug Ineffective |
9.9% |
| Weight Increased |
9.3% |
| Dizziness |
7.5% |
| Hypotension |
7.0% |
| Nausea |
5.5% |
| Blood Pressure Increased |
4.4% |
| Headache |
4.2% |
| Pain In Extremity |
4.2% |
| Somnolence |
4.2% |
| Malaise |
3.7% |
| Palpitations |
3.7% |
| Diarrhoea |
3.5% |
| Dyspnoea |
3.5% |
| Death |
3.3% |
| Oedema Peripheral |
3.3% |
| Vision Blurred |
3.3% |
| Heart Rate Decreased |
3.1% |
| Rash |
3.1% |
| Hypertension |
2.9% |
|
| Secondary |
| Hypertension |
42.3% |
| Drug Use For Unknown Indication |
16.4% |
| Cardiomyopathy |
9.2% |
| Product Used For Unknown Indication |
6.5% |
| Left Ventricular Dysfunction |
4.2% |
| Cardiac Failure Congestive |
2.4% |
| Asthma |
2.1% |
| Blood Cholesterol Abnormal |
2.1% |
| Blood Pressure Abnormal |
2.1% |
| Cardiac Failure |
1.8% |
| Arrhythmia |
1.5% |
| Cardiac Disorder |
1.5% |
| Colonoscopy |
1.5% |
| Atrial Fibrillation |
1.2% |
| Benign Prostatic Hyperplasia |
0.9% |
| Cardiac Septal Defect |
0.9% |
| Hyperlipidaemia |
0.9% |
| Myocardial Infarction |
0.9% |
| Prophylaxis |
0.9% |
| Ventricular Extrasystoles |
0.9% |
|
| Fatigue |
12.0% |
| Weight Increased |
9.0% |
| Drug Ineffective |
8.0% |
| Dyspnoea |
7.0% |
| Hypotension |
7.0% |
| Weight Loss Poor |
7.0% |
| Product Quality Issue |
6.0% |
| Palpitations |
5.0% |
| Medication Error |
4.0% |
| Pharmaceutical Product Complaint |
4.0% |
| Syncope |
4.0% |
| Dizziness |
3.0% |
| Nausea |
3.0% |
| Somnolence |
3.0% |
| Thyroid Disorder |
3.0% |
| Urticaria |
3.0% |
| Ventricular Extrasystoles |
3.0% |
| Visual Acuity Reduced |
3.0% |
| Weight Decreased |
3.0% |
| Wheezing |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.0% |
| Drug Use For Unknown Indication |
14.8% |
| Hypertension |
13.2% |
| Gastrooesophageal Reflux Disease |
5.7% |
| Dyspepsia |
5.6% |
| Atrial Fibrillation |
5.5% |
| Prophylaxis |
5.2% |
| Cardiac Disorder |
4.3% |
| Diabetes Mellitus |
3.9% |
| Pain |
3.4% |
| Type 2 Diabetes Mellitus |
2.9% |
| Rheumatoid Arthritis |
2.6% |
| Blood Cholesterol Increased |
2.5% |
| Hepatitis C |
2.5% |
| Cardiomyopathy |
2.1% |
| Cardiac Failure Congestive |
2.0% |
| Osteoporosis |
2.0% |
| Anxiety |
1.6% |
| Blood Cholesterol |
1.6% |
| Depression |
1.6% |
|
| Myocardial Infarction |
12.4% |
| Death |
7.4% |
| Pruritus |
7.4% |
| Drug Ineffective |
5.8% |
| Pain In Extremity |
5.8% |
| Diarrhoea |
5.0% |
| Mental Status Changes |
5.0% |
| Off Label Use |
5.0% |
| Tremor |
5.0% |
| Vomiting |
5.0% |
| Blood Pressure Increased |
4.1% |
| Hypotension |
4.1% |
| Pyrexia |
4.1% |
| Vision Blurred |
4.1% |
| Cardiac Failure Congestive |
3.3% |
| Constipation |
3.3% |
| Headache |
3.3% |
| Muscle Spasms |
3.3% |
| Myalgia |
3.3% |
| Oedema Peripheral |
3.3% |
|
| Interacting |
| Cardiomyopathy |
61.5% |
| Hypothyroidism |
15.4% |
| Product Used For Unknown Indication |
15.4% |
| Angina Pectoris |
7.7% |
|
| Nausea |
50.0% |
| Thyroid Function Test Abnormal |
50.0% |
|
